chr5-1466761-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024830.5(LPCAT1):āc.1408A>Cā(p.Lys470Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,611,432 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024830.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LPCAT1 | ENST00000283415.4 | c.1408A>C | p.Lys470Gln | missense_variant | 13/14 | 1 | NM_024830.5 | ENSP00000283415.3 | ||
LPCAT1 | ENST00000475622.5 | n.1408A>C | non_coding_transcript_exon_variant | 13/17 | 5 | ENSP00000423472.1 | ||||
LPCAT1 | ENST00000503252.1 | n.275A>C | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152118Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000168 AC: 42AN: 249428Hom.: 0 AF XY: 0.000170 AC XY: 23AN XY: 134938
GnomAD4 exome AF: 0.000132 AC: 192AN: 1459314Hom.: 0 Cov.: 35 AF XY: 0.000129 AC XY: 94AN XY: 726042
GnomAD4 genome AF: 0.000118 AC: 18AN: 152118Hom.: 0 Cov.: 33 AF XY: 0.0000808 AC XY: 6AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2024 | The c.1408A>C (p.K470Q) alteration is located in exon 13 (coding exon 13) of the LPCAT1 gene. This alteration results from a A to C substitution at nucleotide position 1408, causing the lysine (K) at amino acid position 470 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at